Imbio to be Acquired by 4DMedical Creating Comprehensive Cardiothoracic Image Analysis Portfolio

Acquisition by global medical company advances powerful analytical imaging technology

Imbio, Inc. (a portfolio company of Minneapolis-based Invenshure LLC), a provider of medical imaging analysis technologies for chronic lung and cardiothoracic diseases, announces it has entered a binding agreement to be acquired by 4DMedical, a leading producer of advanced lung function imaging software. The combined technology offering will turn any standard chest CT into a much broader Cardiothoracic Analysis, immediately providing functional, structural, and risk-based analysis for both lung and heart disease.

Imbio’s technology provides quantitative and personalized imaging analysis for patients with acute and chronic diseases. The automated system transforms chest CT studies into visual lung maps, generating detailed reports on abnormalities. Imbio algorithms support various clinical initiatives, including lung cancer screening, smoking cessation, surgical planning, and pulmonary embolism management. Additionally, they are leveraged in clinical trials and academic research for diverse diseases.

Imbio is very excited to join forces with 4DMedical to create the leading lung imaging AI suite in the market, combining 4DMedical’s functional analysis with Imbio’s anatomical and tissue analysis. Together we can help clinicians around the globe detect disease earlier, make more robust diagnosis, and drive more informed and confident decision-making for better patient care,” said Dave Hannes, CEO at Imbio.

“This merger represents the culmination of a multi-year effort by Invenshure to create and build Imbio into a preeminent healthcare technology company. Partnering with 4DMedical to create a unified offering and platform will maximize patient impact and shareholder value,” said Danny Cunagin, Chairman of Imbio and Co-CEO of Invenshure.

“I am extremely excited to join forces with the incredibly talented and committed Imbio team. Imbio’s market-leading suite of AI solutions provide life-changing insights from CT scans, and perfectly complements 4DMedical’s functional imaging technology,” says Andreas Fouras, Founder and CEO of 4DMedical. “We now offer a comprehensive cardiothoracic imaging solution set to providers and their patients. Importantly, the Imbio acquisition also boosts our commitment to improve veteran pulmonary health care—especially for those impacted by toxic exposures during service.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

In addition, Wave Neuroscience has acquired the Neuro-EEG Synchronization Therapy (NEST®) system developed and tested by NeoSync.
Boston Scientific expects to complete the transaction in the first half of 2024, subject to customary closing conditions.
E Tech Group announces the immediate renaming of E-Volve Systems to E Tech Group, following their strategic acquisition on February 23, 2023, emphasizing a unified vision, expanded services, and enhanced client and market value through this integration.
ClorDiSys is a family-owned and operated company that began in 2001 as a decontamination equipment provider but quickly added surface-top disinfection products, as well as on-site decontamination services to its portfolio to better address customer challenges
Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.

By using this website you agree to accept Medical Device News Magazine Privacy Policy